4
Changes in Ownership
ACADIA PHARMACEUTICALS INC Filed Acc 0001209191-20-055317
EVP and CCO sold 1,247 shares at $42.56 ($53,072)
- EVP and CCO acquired 2,500 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| YANG MICHAEL J. EVP and CCO | 2020-10-15 | Option exercise | +2,500 | 7,704 | D | ||
| YANG MICHAEL J. EVP and CCO | 2020-10-16 | Sale | −1,247 | $42.56 | $53,072 | 6,457 | D |
| Derivatives | |||||||
| YANG MICHAEL J. EVP and CCO | 2020-10-15 | Option exercise · Restricted Stock Units | −2,500 | 5,000 | D | ||
| Open-market sales · 1,247 sh · avg $42.56 · $53,072 | |||||||
Loading xslF345X03/doc4.xml…